Bio-Rad Laboratories, Inc.
BIO
$245.01
-$6.14-2.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -189.38% | -388.81% | -209.45% | -68.57% | 82.43% |
| Total Depreciation and Amortization | 3.91% | 3.74% | 4.82% | 5.66% | 6.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 113.12% | 118.26% | 111.45% | 11.80% | -75.46% |
| Change in Net Operating Assets | -43.44% | -48.78% | -42.17% | 28.81% | 73.12% |
| Cash from Operations | 21.42% | 10.30% | 20.69% | 43.20% | 92.85% |
| Capital Expenditure | -5.68% | -10.53% | -27.17% | -39.61% | -38.94% |
| Sale of Property, Plant, and Equipment | -50.00% | 62.25% | 175.00% | 40.37% | 24.22% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | 83.82% | 83.82% |
| Other Investing Activities | -96.96% | 171.78% | 252.19% | 239.88% | 117.50% |
| Cash from Investing | -893.07% | 48.01% | 94.02% | 113.15% | 101.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 20.00% | -3.66% | -3.70% | 3.45% | 1.96% |
| Issuance of Common Stock | 3.78% | 6.01% | 2.84% | 9.96% | 5.35% |
| Repurchase of Common Stock | 53.34% | -24.88% | -9.57% | -95.23% | -93.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1,185.42% | -1,185.42% | -1,185.42% | -- |
| Cash from Financing | 48.59% | -26.14% | -10.18% | -102.39% | -143.72% |
| Foreign Exchange rate Adjustments | 2,200.00% | 33.49% | 162.15% | 185.86% | -86.58% |
| Miscellaneous Cash Flow Adjustments | -- | 20.93% | -100.00% | -100.00% | -100.00% |
| Net Change in Cash | 383.72% | 23.16% | 108.39% | 90.93% | 17.73% |
